A permanent KPSGILL section

Healthcare Controversies

Evidence, power, conscience, and accountability

Fifteen categories and 150 questions that medicine prefers not to ask in public — from conscience and competence in gender-dysphoria care to Fresno's Medi-Cal economics, encounter-based payment, investor control and AI-written records — each with a visible status, and nine evidence-graded opening investigations.

  • Sections 15 categories · 150 topics
  • Opening analyses 9 new · 1 existing series
  • Status shown Published · existing · partial · planned
  • Checked

Why this section exists

Medicine's hardest disputes are rarely about a single fact. They are about who is entitled to decide, who is paid for the decision, who has the time, training and staff to carry it out, and who remains answerable when care is delayed, fragmented or never completed. Those questions run beneath conflicts that are usually argued in slogans: whether a physician may decline to provide a treatment on grounds of conscience or competence; whether a county where roughly half the population is enrolled in Medi-Cal can sustain independent practices; whether payment by the visit rewards activity rather than finished care; whether investors who cannot practise medicine may nonetheless control the practice; whether a physician who signs a note drafted by software has written it.

Healthcare Controversies is a permanent section built to examine those disputes with the same discipline this site applies to court records and corporate structures. It does not begin from a verdict. Each topic is written first as a question that evidence could answer — and could answer against the premise that prompted it. Each analysis identifies the precise intervention or institutional practice, the population and dates, the legal or clinical standard and its issuer and status, the strongest competing explanation, and the evidence that would change the conclusion.

  • Who decides?The clinician, the employer, the plan, the board, the investor, the agency or the court — and under what authority.
  • Who is paid?The payment unit, the payee and the incentive it creates, read from the rule rather than inferred from outcomes.
  • Who has the resources?Training, staff, specialists, time and money — the capacity that turns an obligation into care.
  • Who remains responsible?When a referral goes nowhere, a result is never acted on, or a service disappears, whose duty was it?

Method, applied to every topic

Specify the population, intervention, institution, geography, dates and denominator. Identify each rule's issuer, legal status, effective date, covered parties and exceptions. Distinguish a complaint, subpoena, warning letter, audit sample, settlement and adjudicated finding. Present the best-supported competing explanation, including evidence inconsistent with the criticism being tested. Distinguish an author's policy or ethical view from a medical finding, doctrinal claim or legal holding. State what would change the conclusion.

The opening investigations

The research brief set twelve priority assignments. Nine new analyses answer them in this edition; overlapping assignments were combined where one substantial article could answer the questions better than two short ones, and assignment 11 is answered by the eight-part physician-authority series already published, which this section links rather than duplicates.

The map: fifteen categories, 150 questions

Every topic below carries a visible status. A card is not an investigation: a Planned label means only that the question has been framed. Where an existing KPSGILL page already addresses a question, the card links to it rather than creating a duplicate; those pages keep their own dates and have not been re-reviewed for this section unless they say so.

Analysis published 39 — a Healthcare Controversies analysis answers the question to the extent the evidence permitsExisting coverage 67 — an existing KPSGILL page addresses it directly; not re-reviewed for this section unless datedPartial coverage 30 — a section of an existing page addresses part of itPlanned · not yet investigated 14 — a research question only; nothing is asserted

Gender-dysphoria care: competence, access, and clinical evidence

Reporting method. Compare guideline versions, original studies, competency requirements, treatment-specific outcomes, and real service availability. Strongest competing concerns: unnecessary barriers to beneficial care and treatment offered without sufficient evidence, preparation, or follow-up.

  1. Topic 001Analysis published

    Different services, different competence

    Distinguish ordinary primary care, diagnostic assessment, psychotherapy, puberty suppression, hormones, surgery, and management of complications.

  2. Topic 002Analysis published

    When does a patient need an endocrinologist?

    Compare appropriately trained primary-care management, specialist consultation, complex endocrine disease, and multidisciplinary adolescent services.

  3. Topic 003Analysis published

    The gender-care specialist shortage

    Measure accepting clinicians, waiting times, travel, insurance participation, and the practical availability of pediatric and adult expertise.

  4. Topic 004Analysis published

    Training, confidence, and demonstrated competence

    Determine what supervised experience, assessment, prescribing knowledge, monitoring skills, and ongoing education a specific service requires.

  5. Topic 005Partial coverage

    Adult evidence and adolescent evidence

    Evaluate each population separately, including consent, developmental issues, treatment goals, comparators, and duration of follow-up.

  6. Topic 006Partial coverage

    What do outcome studies actually establish?

    Examine mental-health outcomes, quality of life, confounding, missing follow-up, and whether causal claims exceed the research design.

  7. Topic 007Partial coverage

    Puberty suppression, fertility, and informed consent

    Investigate what is known, uncertain, and communicated about skeletal development, fertility preservation, sexual function, and later treatment.

  8. Topic 008Planned · not yet investigated

    Mental-health assessment without predetermined conclusions

    Examine differential diagnosis, coexisting conditions, decision-making capacity, psychosocial support, and individualized treatment planning.

    No KPSGILL analysis yet. Listed so the gap is visible.

  9. Topic 009Partial coverage

    Discontinuation, regret, and changing treatment goals

    Distinguish detransition, interrupted access, adverse effects, regret, and evolving preferences; require meaningful denominators and follow-up.

  10. Topic 010Analysis published

    Continuity when gender-care services disappear

    Investigate safe transitions when clinics close, clinicians withdraw, coverage changes, or patients move across jurisdictions.

Religion, conscience, patient rights, and government authority

Reporting method. Build a service-by-jurisdiction legal matrix and distinguish government action, employer duties, professional duties, and patient rights. Strongest competing concerns: compelled participation and unjustified denial of access.

  1. Topic 011Analysis published

    How many physicians object, and why?

    Separate religious objection, other ethical concerns, insufficient training, inadequate resources, and low demand; disclose every survey's sampling limits.

  2. Topic 012Analysis published

    Declining a treatment versus declining a patient

    Examine the legal boundary between a service-specific limitation and denial of otherwise available care based on patient identity.

  3. Topic 013Analysis published

    The statutory protection for genuine lack of qualification

    Analyze California Business and Professions Code section 125.6(b)(2), documentation of competence, and the section's nondiscrimination provisions.

  4. Topic 014Analysis published

    Religious accommodation inside a medical practice

    Apply the employment-law framework to scheduling, staffing, job duties, alternatives, and practical effects on patient access.

  5. Topic 015Analysis published

    Faith, personal conscience, and religious diversity

    Compare individual beliefs and differing interpretations within traditions; do not presume every member of a religion shares one position.

  6. Topic 016Analysis published

    Does conscience protection include refusing a referral?

    Compare specific legal protections, professional guidance, contractual responsibilities, and the availability of another willing clinician.

  7. Topic 017Analysis published

    Respectful care despite moral disagreement

    Explore communication, ordinary treatment, emergency obligations, patient dignity, and professional boundaries without requiring theological agreement.

  8. Topic 018Analysis published

    Federal conscience rights and California civil rights

    Read RFRA cases, Benitez, Section 1557 litigation, and state protections according to the parties, conduct, and remedies actually covered.

  9. Topic 019Analysis published

    Who pays when federal and state gender-care policies diverge?

    Follow the October 2026 youth-service reimbursement changes, California's separate funding arrangements, and effects on willing providers and patients.

  10. Topic 020Analysis published

    Investigative subpoenas and state shield laws

    Examine medical-record access, lawful prescribing, regulatory investigations, and the difference between a subpoena ruling and a finding of wrongdoing.

Fresno, Medi-Cal, and independent-practice economics

Reporting method. Combine dated enrollment, real practice finances, workforce data, and appointment testing. Strongest counterargument: payer mix alone does not explain practice viability.

  1. Topic 021Analysis published

    A county where roughly half the population has Medi-Cal

    Explain the dated enrollment evidence, pediatric concentration, population denominators, and what county averages conceal.

  2. Topic 022Analysis published

    Can an independent Medi-Cal practice cover its costs?

    Model collected revenue, payer mix, staffing, rent, malpractice, administrative work, visit capacity, and realistic physician compensation.

  3. Topic 023Analysis published

    County payer mix versus a practice's actual panel

    Test whether financially successful practices serve representative populations or depend on selective networks, geography, specialties, or commercial coverage.

  4. Topic 024Analysis published

    Do targeted rate increases reach treating clinicians?

    Track eligible services, intermediary contracts, capitation adjustments, payment delays, and whether participation and access improve.

  5. Topic 025Analysis published

    Reimbursement shortage or workforce shortage?

    Separate payment problems from specialty distribution, residency capacity, recruitment, retention, and the number of clinicians accepting new patients.

  6. Topic 026Analysis published

    An insurance card without a specialist appointment

    Audit network listings against actual scheduling, referral rejection, travel distances, telehealth availability, and plan accountability.

  7. Topic 027Analysis published

    The cost of language, transport, and unstable work schedules

    Measure the resources needed to make care usable for patients facing access barriers and identify who finances them.

  8. Topic 028Analysis published

    The unpaid work behind a Medi-Cal visit

    Quantify authorizations, forms, results review, medication reconciliation, interpreter coordination, and work performed between visits.

  9. Topic 029Existing coverage

    Hospital and service-line closures in the Valley

    Test consequences for maternity, emergency, behavioral-health, and specialty access, including the burdens shifted to primary care.

  10. Topic 030Analysis published

    What would make independent practice viable?

    Compare payment reform, shared administrative services, physician cooperatives, care-management funding, and recruitment support using transparent assumptions.

FQHCs: encounters, continuity, governance, and outcomes

Reporting method. Compare actual processes and outcomes with HRSA requirements, payer contracts, and payment design. Strongest counterargument: higher patient complexity and broader service obligations make simple visit comparisons misleading.

  1. Topic 031Analysis published

    Does encounter payment reward extra visits?

    Test clinically justified follow-up against avoidable fragmentation, repeat trips, and care that could safely be completed without another visit.

  2. Topic 032Analysis published

    Who owns the patient's unfinished care plan?

    Map responsibility for referrals, abnormal results, medication changes, and hospital follow-up across clinicians, centers, plans, and contractors.

  3. Topic 033Analysis published

    FQHC reimbursement versus independent-office reimbursement

    Compare the complete service bundle, patient complexity, enabling services, overhead, and public obligations before drawing conclusions from different prices.

  4. Topic 034Analysis published

    Capitation's promise and its underservice risk

    Evaluate whether alternative payment improves access and continuity while protecting complex patients from inadequate care or excessive panel sizes.

  5. Topic 035Analysis published

    Referral completion as an accountability measure

    Track whether consultations happen, recommendations return, and someone acts; distinguish an electronic referral order from completed care.

  6. Topic 036Analysis published

    Productivity targets and medically complex patients

    Examine appointment duration, interpretation, staffing, protected administrative time, and adjustments for complexity rather than raw encounters alone.

  7. Topic 037Planned · not yet investigated

    Expansion, clinician turnover, and continuity

    Compare new locations and growing visit totals with retention, stable patient-clinician relationships, and timely access.

    No KPSGILL analysis yet. Listed so the gap is visible.

  8. Topic 038Planned · not yet investigated

    Patient-majority governance and actual influence

    Investigate board information, patient participation, financial oversight, service decisions, and whether complaints change institutional behavior.

    No KPSGILL analysis yet. Listed so the gap is visible.

  9. Topic 039Existing coverage

    Public support, 340B revenue, and community benefit

    Trace financial benefits to patient affordability and services while distinguishing grant recipients, look-alikes, and separately applicable protections.

  10. Topic 040Analysis published

    A public scorecard for whole-person care

    Design risk-adjusted measures of access, completed follow-up, preventable harm, patient experience, and continuity that patients can understand.

Corporate ownership, investors, and clinical control

Reporting method. Trace contracts and actual decision authority alongside finances and outcomes. Strongest counterargument: capital and shared administration can preserve access and improve operations.

  1. Topic 041Analysis published

    Who actually controls a professional corporation?

    Compare formal ownership with contracts, budgets, hiring powers, clinical vetoes, and the practical ability to reject management directives.

  2. Topic 042Analysis published

    Management agreements that influence medical decisions

    Examine scheduling, staffing, referral restrictions, equipment, prescribing policies, and boundaries between administration and professional judgment.

  3. Topic 043Analysis published

    The physician-owner succession agreement

    Investigate stock-transfer powers and removal provisions to determine whether nominal ownership carries meaningful independent authority.

  4. Topic 044Analysis published

    Private equity, debt, and patient continuity

    Compare borrowing, distributions, staffing, turnover, service closures, and outcomes before and after acquisition without assuming causation.

  5. Topic 045Analysis published

    Clinical independence after California's SB 351

    Track enforceable restrictions, exceptions, evidence of interference, enforcement activity, and the difference between statutory protection and practical control.

  6. Topic 046Existing coverage

    Hospital consolidation and referral concentration

    Test whether integration improves coordination or limits alternatives, raises prices, and concentrates bargaining power.

  7. Topic 047Existing coverage

    Revenue-based management fees and fee-splitting

    Distinguish legitimate administrative compensation from arrangements that require scrutiny under applicable professional-practice and payment laws.

  8. Topic 048Existing coverage

    Productivity bonuses and clinician treatment choices

    Study whether incentives influence testing, procedures, referrals, visit frequency, or the time available for complex decisions.

  9. Topic 049Planned · not yet investigated

    Dental service organizations and corporate dentistry

    Examine treatment quotas, ownership, clinical authority, staffing, infection-control resources, and the ability to resist inappropriate directives.

    No KPSGILL analysis yet. Listed so the gap is visible.

  10. Topic 050Existing coverage

    Bankruptcy after healthcare expansion

    Trace continuity obligations, patient records, insurance, creditor rights, employee claims, and responsibility for the reorganized enterprise.

Licensing, certification, medical boards, and due process

Reporting method. Identify the precise gatekeeper, legal authority, competency rationale, and appeal process. Strongest counterargument: genuine public-protection standards should not be equated with anticompetitive exclusion.

  1. Topic 051Existing coverage

    A license to practice and permission to earn a living

    Map how hospitals, insurers, employers, and specialty boards can restrict work despite an active state medical license.

  2. Topic 052Existing coverage

    Maintenance of certification and measurable competence

    Compare costs, relevant learning, assessment quality, patient outcomes, alternative approaches, and the evidence supporting mandatory participation.

  3. Topic 053Existing coverage

    Alternative certification and network exclusion

    Evaluate credentialing criteria, consistent application, appeal rights, grandfathering, and whether exclusions reflect demonstrated competence.

  4. Topic 054Existing coverage

    The Interstate Compact's eligibility filters

    Examine which physicians qualify for expedited licensing, who uses ordinary pathways, and whether the distinctions improve public protection.

  5. Topic 055Existing coverage

    FSMB influence and actual legal authority

    Trace databases, policy recommendations, credential services, finances, and state decisions without conflating organizational influence with statutory licensing power.

  6. Topic 056Existing coverage

    NPI reporting, credentialing, and enrollment barriers

    Distinguish an identifier from a license, specialty certification, payer enrollment, and a board's workforce-information requirements.

  7. Topic 057Existing coverage

    Reciprocal discipline across multiple states

    Examine independent review, notice, emergency action, appeal rights, and the consequences of another jurisdiction's findings.

  8. Topic 058Existing coverage

    Medical-board secrecy, delay, and public protection

    Compare complaint handling, investigation duration, closure reasons, published outcomes, and fairness to both patients and clinicians.

  9. Topic 059Existing coverage

    Peer review and competitive retaliation

    Test allegations of improper exclusion against clinical records, independent review, statutory protections, hearing procedures, and commercial relationships.

  10. Topic 060Existing coverage

    Mental-health treatment and fitness-to-practice inquiries

    Evaluate whether credentialing questions assess current impairment or discourage clinicians from seeking appropriate care.

Insurance, prior authorization, networks, and access

Reporting method. Study patient-level timelines, criteria, decisions, appeals, and clinical consequences with proper denominators. Strongest counterargument: utilization controls can reduce unnecessary or unsafe care.

  1. Topic 061Existing coverage

    Faster prior authorization and actual treatment access

    Audit the applicable 2026 deadlines and denial explanations, then measure whether reforms shorten the patient's path to care.

  2. Topic 062Existing coverage

    The appeal that reverses the original denial

    Investigate clinical reasons, avoidable delay, patient harm, and the unpaid work needed to obtain reconsideration.

  3. Topic 063Partial coverage

    Proprietary medical-necessity criteria

    Examine access to the operative criteria, evidence updates, patient-specific exceptions, and the qualifications of reviewers.

  4. Topic 064Analysis published

    Delegated decisions and retained insurer responsibility

    Map the plan, administrator, medical group, utilization vendor, and treating clinician without allowing delegation to obscure obligations.

  5. Topic 065Existing coverage

    Algorithms in coverage denials

    Determine whether software supports or replaces individualized review and whether audit trails permit a meaningful appeal.

  6. Topic 066Existing coverage

    Risk adjustment and diagnosis-driven revenue

    Distinguish accurate recognition of patient complexity from unsupported diagnoses, coding pressure, and payments disconnected from additional care.

  7. Topic 067Existing coverage

    Capitation and incentives to limit services

    Test risk adjustment, specialty access, complex-patient outcomes, payment distribution, and safeguards against undertreatment.

  8. Topic 068Partial coverage

    Fee-for-service and incentives to do more

    Apply comparable scrutiny to unnecessary testing, procedures, repeat visits, and services with limited patient benefit.

  9. Topic 069Existing coverage

    Network directories, narrow networks, and continuity

    Verify actual new-patient access, clinician departures, out-of-network exceptions, and continuity when a contract ends.

  10. Topic 070Partial coverage

    Medicare Advantage, post-acute care, and discharge pressure

    Examine rehabilitation, home-health, and nursing-facility decisions using clinical need, review findings, appeals, and patient outcomes.

Physician work, labor rights, training, and professional responsibility

Reporting method. Document workload, actual supervision, contractual roles, safety systems, and fair accommodations. Strongest counterargument: legitimate staffing and credentialing requirements are essential to patient protection.

  1. Topic 071Partial coverage

    Who pays for the physician's inbox?

    Measure uncompensated clinical work, after-hours time, staffing alternatives, and how payment models allocate responsibility.

  2. Topic 072Existing coverage

    Unsafe workloads and the right to raise concerns

    Examine staffing evidence, escalation procedures, contractual duties, retaliation allegations, and patient-safety consequences.

  3. Topic 073Existing coverage

    Burnout, moral distress, and working conditions

    Compare individual resilience programs with changes to schedules, staffing, administrative work, control, and clinical resources.

  4. Topic 074Existing coverage

    Employed-physician autonomy and management authority

    Determine which workplace decisions are ordinary management and which interfere with professional judgment or lawful patient advocacy.

  5. Topic 075Existing coverage

    Noncompetes, nonsolicitation, and patient choice

    Analyze controlling state law, contractual restrictions, sale-of-business exceptions, and practical barriers when a physician changes employers.

  6. Topic 076Existing coverage

    NP and PA practice: access, supervision, and patient complexity

    Compare training, supervision actually provided, referral patterns, outcomes, team design, and total costs.

  7. Topic 077Planned · not yet investigated

    Signing care that was not meaningfully supervised

    Investigate responsibility for charts, orders, remote oversight, staffing models, and accurate representations to patients and payers.

    No KPSGILL analysis yet. Listed so the gap is visible.

  8. Topic 078Existing coverage

    Internationally trained physicians and alternative pathways

    Evaluate competency assessment, supervision, access gains, employment dependence, and safeguards in new licensing routes.

  9. Topic 079Existing coverage

    Visa dependence and bargaining power

    Examine recruitment contracts, work-site restrictions, reporting of safety concerns, and consequences when a practice closes or changes ownership.

  10. Topic 080Existing coverage

    Physicians as patients and employees

    Investigate disability accommodation, medical leave, pregnancy, aging, discrimination, and fair assessment of the ability to practice safely.

Pharmaceuticals, research evidence, and commercial medicine

Reporting method. Compare protocols, original studies, trial registries, regulatory status, marketing, and financial relationships. Strongest counterargument: commercial funding and off-label care can meet legitimate clinical needs.

  1. Topic 081Partial coverage

    Guideline conflicts and the recommendation process

    Examine disclosures, recusals, study selection, evidence grading, external review, and relationships that could influence recommendations.

  2. Topic 082Planned · not yet investigated

    Disease thresholds and expanding treatment markets

    Evaluate absolute benefit, overdiagnosis, labeling, patient preference, and financial consequences when diagnostic thresholds change.

    No KPSGILL analysis yet. Listed so the gap is visible.

  3. Topic 083Existing coverage

    Accelerated approval and unconfirmed benefit

    Track surrogate endpoints, required confirmatory trials, delayed studies, withdrawn indications, and what patients are told.

  4. Topic 084Planned · not yet investigated

    Off-label prescribing and informed clinical judgment

    Distinguish lawful individualized treatment, strength of evidence, informed consent, and misleading commercial promotion.

    No KPSGILL analysis yet. Listed so the gap is visible.

  5. Topic 085Existing coverage

    GLP-1 prescribing, compounding, and access

    Compare clinical eligibility, continuity, cost, product quality, pharmacy practices, and claims made by online businesses.

  6. Topic 086Partial coverage

    Peptides, longevity clinics, and expensive uncertainty

    Audit regulatory status, patient selection, evidence, consent, financial conflicts, and adverse-event reporting.

  7. Topic 087Partial coverage

    Prescribing businesses that also sell the treatment

    Trace advertising, clinical evaluation, prescriptions, dispensing, subscriptions, and incentives within vertically integrated services.

  8. Topic 088Existing coverage

    Drug shortages and allocation decisions

    Examine purchasing arrangements, manufacturing reliability, substitution, patient prioritization, and who bears the cost of scarcity.

  9. Topic 089Planned · not yet investigated

    Industry-funded education and clinical independence

    Compare educational quality, promotional content, speaker compensation, disclosed relationships, and independent learning alternatives.

    No KPSGILL analysis yet. Listed so the gap is visible.

  10. Topic 090Existing coverage

    Missing trials, selective publication, and research misconduct

    Track protocols, outcome changes, unpublished results, corrections, retractions, and the consequences for guidelines and patient care.

AI, digital medicine, health records, and privacy

Reporting method. Examine intended use, local validation, errors, audit trails, consent, contractual responsibility, and independent performance data. Strongest counterargument: well-governed technology can improve safety and reduce administrative burdens.

  1. Topic 091Analysis published

    The physician who signs an inaccurate AI note

    Allocate responsibility among clinician, employer, software vendor, and system designer using verification workflows and audit trails.

  2. Topic 092Analysis published

    AI diagnoses and orders before clinical review

    Examine automation bias, unsupported additions, delayed correction, training, and patient safety when generated content enters clinical workflows.

  3. Topic 093Partial coverage

    Ambient recording and meaningful patient choice

    Evaluate consent, retention, language accuracy, secondary use, and practical alternatives for patients who decline recording.

  4. Topic 094Partial coverage

    When a chatbot presents itself as a clinician

    Examine professional-title restrictions, disclosures, patient reliance, escalation procedures, and California's AI-related requirements.

  5. Topic 095Existing coverage

    Medical AI outside FDA device regulation

    Explain the regulatory boundary and ask what independent validation and accountability remain when a product is not a regulated device.

  6. Topic 096Existing coverage

    Algorithmic bias across patient populations

    Test performance by language, disability, age, sex, race, disease severity, and local practice setting rather than aggregate accuracy alone.

  7. Topic 097Existing coverage

    Who profits from patient data?

    Map consent, de-identification, secondary licensing, re-identification risk, commercial value, and whether patients can meaningfully object.

  8. Topic 098Partial coverage

    EHR lock-in and obstructed patient choice

    Investigate interoperability, fees, data migration, record access, and clinical disruption when practices or vendors change.

  9. Topic 099Existing coverage

    Cyberattacks and clinical continuity

    Assess downtime planning, medication safety, diverted care, delayed payments, breach response, and vendor responsibility.

  10. Topic 100Partial coverage

    Sensitive treatment records used for benefit eligibility

    Examine whether data sharing reduces paperwork while protecting addiction-treatment, reproductive, and other highly sensitive information.

Reproduction, consent, disability, and end-of-life decisions

Reporting method. Identify the exact decision, patient capacity, governing law, safeguards, alternatives, and practical access. Strongest competing concerns include autonomy, conscience, preservation of life, disability rights, and protection from coercion.

  1. Topic 101Existing coverage

    Emergency pregnancy care under conflicting legal duties

    Identify the actual clinical decision, governing statutes, injunctions, hospital protocols, and consequences of delayed treatment.

  2. Topic 102Partial coverage

    Religious hospitals and advance notice of service restrictions

    Ask when patients learn of restrictions, whether alternatives are accessible, and how emergencies and continuity are handled.

  3. Topic 103Partial coverage

    Institutional conscience versus the treating clinician's conscience

    Examine whose beliefs control a hospital's policy and what options remain for employed clinicians and patients.

  4. Topic 104Partial coverage

    Contraception, sterilization, and reproductive autonomy

    Investigate informed consent, paternalism, coercion, disability bias, access, and treatment-specific clinician objections.

  5. Topic 105Planned · not yet investigated

    IVF, embryo status, and reproductive decision-making

    Trace storage, disposal, genetic testing, consent disputes, liability, and affordability under differing legal frameworks.

    No KPSGILL analysis yet. Listed so the gap is visible.

  6. Topic 106Partial coverage

    Cross-state telemedicine and shield-law conflicts

    Distinguish protection in the treating state from exposure elsewhere, enforcement tools, and unresolved jurisdictional questions.

  7. Topic 107Partial coverage

    Consent forms that patients cannot meaningfully understand

    Evaluate interpretation, health literacy, time pressure, financial disclosure, alternatives, and documentation of an actual discussion.

  8. Topic 108Existing coverage

    Medical aid in dying and the availability of supportive care

    Examine voluntariness, safeguards, disability concerns, clinician participation, and equitable access to palliative and social support.

  9. Topic 109Partial coverage

    Disagreement over medically ineffective treatment

    Analyze authority, independent review, family participation, transfer options, and procedural fairness in life-support disputes.

  10. Topic 110Planned · not yet investigated

    Organ allocation and disputed measures of social worth

    Examine eligibility criteria, disability, adherence assessments, insurance barriers, transparency, and the evidence supporting exclusion.

    No KPSGILL analysis yet. Listed so the gap is visible.

Mental health, addiction, coercion, and treatment access

Reporting method. Separate legal authority from clinical efficacy and measure continuity, capacity, consent, adverse effects, and outcomes. Strongest competing concerns: harmful coercion and the consequences of unavailable effective treatment.

  1. Topic 111Existing coverage

    Involuntary treatment and a patient's right to refuse

    Compare statutory criteria, decision-making capacity, evidence of benefit, due process, and realistic access to voluntary care.

  2. Topic 112Existing coverage

    Court-directed care when housing and clinicians are unavailable

    Test whether legal orders are matched by treatment capacity, stable housing, follow-up, and measurable outcomes.

  3. Topic 113Partial coverage

    Primary care as the default psychiatric service

    Examine specialist scarcity, diagnostic uncertainty, medication monitoring, consultation support, and the burden placed on generalists.

  4. Topic 114Partial coverage

    Suicide-risk documentation and actual protection

    Distinguish completed templates from assessment, safety planning, continuity, escalation, and access to appropriate treatment.

  5. Topic 115Planned · not yet investigated

    Long-term psychiatric medication and informed choice

    Evaluate ongoing benefit, adverse effects, withdrawal, deprescribing, shared decisions, and access to nonpharmacologic options.

    No KPSGILL analysis yet. Listed so the gap is visible.

  6. Topic 116Planned · not yet investigated

    Pain care between undertreatment and opioid harm

    Investigate patient selection, monitoring, abrupt discontinuation, access to alternatives, and the effects of enforcement fears.

    No KPSGILL analysis yet. Listed so the gap is visible.

  7. Topic 117Planned · not yet investigated

    Addiction treatment as a recurring revenue stream

    Examine financial incentives, unnecessary testing, admissions, retention, discharge, and independently measured recovery outcomes.

    No KPSGILL analysis yet. Listed so the gap is visible.

  8. Topic 118Existing coverage

    Medications for opioid-use disorder and institutional resistance

    Evaluate access, evidence, stigma, staffing, continuity, and treatment interruptions across hospitals, clinics, and custody settings.

  9. Topic 119Existing coverage

    Ketamine, psychedelics, and commercialization ahead of evidence

    Differentiate approved uses, research, off-label care, marketing, patient vulnerability, and long-term monitoring.

  10. Topic 120Existing coverage

    Addiction-record privacy and coordinated care

    Analyze when information exchange improves safety, what consent permits, and how inappropriate reuse can deter patients from treatment.

Correctional care and settings with limited patient choice

Reporting method. Compare contracts, inspections, court records, staffing, and documented patient journeys. Strongest counterargument: security and operational constraints are real, but their actual effects and available alternatives require evidence.

  1. Topic 121Existing coverage

    Correctional-health contracts and clinical incentives

    Examine staffing promises, off-site referrals, cost risk, performance penalties, quality reporting, and enforcement.

  2. Topic 122Existing coverage

    Custody authority versus medical authority

    Map control over observation, restraint, transport, medication access, privacy, and emergency escalation.

  3. Topic 123Existing coverage

    Medical necessity when a referral requires security transport

    Test whether scheduling and cost barriers cause clinically significant delay and how escalation decisions are documented.

  4. Topic 124Existing coverage

    Deaths in custody and independent review

    Examine review independence, access to records, causal findings, corrective actions, and public accountability.

  5. Topic 125Existing coverage

    Release from custody without a completed care transition

    Track medication supply, records, coverage, follow-up appointments, and responsibility for high-risk handoffs.

  6. Topic 126Existing coverage

    Bankruptcy and the survival of patient claims

    Distinguish claims deadlines, the automatic stay, insurance, releases, reorganized entities, and access to records.

  7. Topic 127Existing coverage

    Nursing-home ownership, staffing, and related-party payments

    Trace money alongside staffing, inspection findings, resident outcomes, and the owner's response.

  8. Topic 128Existing coverage

    Hospice enrollment, prognostic uncertainty, and financial incentives

    Investigate eligibility, consent, services delivered, live discharge, family understanding, and evidence of benefit or misuse.

  9. Topic 129Partial coverage

    Disability and chronic illness in healthcare rationing

    Evaluate communication access, appointment resources, diagnostic overshadowing, and assumptions about quality of life.

  10. Topic 130Existing coverage

    Immigration status, institutional fear, and access to treatment

    Examine coverage rules, confidentiality, actual enforcement policies, and whether patients can obtain timely care.

Public health, contested science, and community trust

Reporting method. Quantify benefits, harms, uncertainty, distribution of burdens, and criteria for revising policy. Strongest counterargument: individual objections and population-level protection cannot be evaluated with slogans.

  1. Topic 131Existing coverage

    Public-health mandates and proportionality

    Compare expected benefit, burden, duration, exemptions, alternatives, and criteria for ending restrictions.

  2. Topic 132Existing coverage

    Vaccine risks, surveillance signals, and compensation

    Distinguish temporally associated reports from established causal risks and examine how uncertainty and compensation are communicated.

  3. Topic 133Existing coverage

    Medical dissent, misinformation, and professional discipline

    Separate scientific disagreement, misleading commercial claims, patient-specific advice, and findings of unsafe practice.

  4. Topic 134Existing coverage

    Guidelines that change and institutions that resist correction

    Investigate how revised evidence reaches clinicians, patients, insurers, and electronic order sets.

  5. Topic 135Partial coverage

    Race-based algorithms and their replacements

    Evaluate biological assumptions, individual consequences, validation, and whether revised methods improve decisions and outcomes.

  6. Topic 136Existing coverage

    Pesticides, air pollution, heat, and Valley health

    Trace exposure data, preventable illness, worker protection, regulatory enforcement, and who finances prevention.

  7. Topic 137Partial coverage

    Food policy, obesity, and conflicting commercial interests

    Compare clinical evidence, affordability, marketing, institutional incentives, and the effectiveness of proposed interventions.

  8. Topic 138Partial coverage

    Schools, parental authority, and adolescent confidentiality

    Examine consent rules, safety concerns, access to confidential care, and conflicts between family involvement and patient protection.

  9. Topic 139Planned · not yet investigated

    Screening, incidental findings, and overdiagnosis

    Quantify absolute benefit, false positives, downstream procedures, patient preferences, and opportunity costs.

    No KPSGILL analysis yet. Listed so the gap is visible.

  10. Topic 140Existing coverage

    Emergency preparedness after the news cycle ends

    Audit staffing, supplies, communication, drills, financial readiness, and public reporting of lessons from past failures.

Public money, litigation, enforcement, and institutional accountability

Reporting method. Trace money, legal elements, procedural posture, evidence, defenses, and subsequent changes. Strongest counterargument: organizational complexity, settlement, or insolvency is not itself proof of fraud or misconduct.

  1. Topic 141Partial coverage

    Nonprofit status and commercial conduct

    Compare tax benefits, community benefit, collections, executive compensation, reserves, and access for patients unable to pay.

  2. Topic 142Existing coverage

    340B savings and the patients meant to benefit

    Follow acquisition discounts, contract-pharmacy arrangements, administrative payments, service investment, and patient affordability.

  3. Topic 143Existing coverage

    False Claims Act cases and the limits of inference

    Analyze alleged falsity, knowledge, materiality, procedural posture, defenses, and the distinction between billing error and fraud.

  4. Topic 144Partial coverage

    Stark and Anti-Kickback rules in local referral markets

    Map remuneration, referral relationships, exceptions, safe harbors, and evidence of actual conduct before drawing legal conclusions.

  5. Topic 145Existing coverage

    Whistleblowers, confidentiality clauses, and retaliation

    Examine protected reporting, proof of causation, internal compliance processes, patient privacy, and available remedies.

  6. Topic 146Existing coverage

    The employer on the form and the entity controlling the work

    Reconcile contracts, payroll, tax filings, benefits, insurance, and operational control without treating any single record as conclusive.

  7. Topic 147Existing coverage

    Deferred compensation when a healthcare company becomes insolvent

    Explain plan promises, funding, creditor exposure, disclosures, benefit classification, and remedies grounded in the actual documents.

  8. Topic 148Existing coverage

    Settlements, no-admission clauses, and what changed afterward

    Separate allegations from findings, evaluate promised reforms, and verify subsequent compliance.

  9. Topic 149Existing coverage

    Public contracts, trade secrets, and access to accountability records

    Examine procurement, performance reporting, confidentiality claims, disclosure rules, and the records needed to evaluate care.

  10. Topic 150Partial coverage

    A healthcare reform that can be tested and disproved

    Compare proposed solutions using cost, access, continuity, outcomes, clinician sustainability, and explicit criteria for success or failure.

How this section could be attacked — and the answers built into it

The strongest attacks

  • Personal conviction is passed off as population-level evidence or binding law.
  • Competence is asserted from a specialty label, or used as an unexplained justification for selective refusal.
  • Small, selected surveys are extrapolated to all physicians.
  • A county's Medi-Cal share is treated as proof that no independent practice can thrive.
  • A payment incentive is treated as proof that an institution neglects patients.
  • Different service bundles or healthier populations are compared as though equivalent.
  • A board, insurer, employer, identifier and certifying body are treated as one licensing authority.
  • A complaint, subpoena, warning letter, settlement and final finding are treated as equivalent.
  • An old dataset is relabeled as current because a page was updated.

The answers

  • Each thesis is a falsifiable question written before the evidence is gathered.
  • Denominators, data periods and sampling limits are printed beside every figure.
  • Each rule is named with its issuer, status, effective date and exceptions.
  • The best-supported competing explanation is presented, including inconvenient evidence.
  • Allegations are attributed; findings are identified by the body that made them.
  • No poll, expert, quotation, outcome or national physician percentage is invented.
  • Material new allegations about a named organisation are not published without its response.
  • Remedies are judged against access, continuity, outcomes and clinician sustainability.

How a topic moves from Planned to Analysis published

A topic is marked Analysis published only when its central question has been answered to the extent the evidence permits, every material assertion is sourced, counterevidence is addressed, dates and procedural posture are correct, and the text separates verified fact from analysis and proposal. Until then the Planned label stays visible. Time-sensitive legal and clinical articles are refreshed against the operative statute, rule, guidance and court posture before they are revised.

Correction history

No corrections since first publication on . Material corrections will be dated here, with the superseded text preserved and labeled.

Reviewed and approved for publication by Kanwar Partap Singh Gill, MD. Healthcare Controversies examines disputes about medical care, institutions, money, conscience and law using public records. It is institutional and legal analysis: not patient-specific clinical guidance, not legal advice, and not a finding about any named clinician or organisation beyond what the cited records establish. Survey figures are reported with their denominators and dates; a funding rule, guideline, audit sample or payment incentive is not treated as proof of more than it measures.

Kanwar Partap Singh Gill, MD
Family Medicine Physician · Fresno, California, USA

Healthcare Controversies · institutional and legal analysis, not patient-specific clinical guidance and not legal advice · proved text, documented data, attributed reports and KPSGILL inference distinguished throughout · public sources only · sources checked 1 November 2026 · Published by Kanwar Partap Singh Gill, MD · .

Search KPSGill.com

Search the full publication — patient guides, policy, investigations, enforcement records and research.